5 Key Takeaways

• 1

  Ablation therapy combined with anti-VEGF injections effectively avoids radiation-related damage in uveal melanoma patients.

• 2

  In a study of 105 patients, all achieved tumor control without radiation, with most maintaining vision of 20/40 or better.

• 3

  Patients' vision improved from an entry level of 20/63 to an average of 20/32 by the end of the study.

• 4

  Tumor-associated maculopathy developed on average at 4 months post-treatment but was responsive to anti-VEGF therapy.

• 5

  Only one patient with GEP class 2 tumor developed metastatic disease, indicating effective local tumor control in the cohort.